Stuttgart - Delayed Quote EUR
Blueprint Medicines Corp (2L9.SG)
75.06
+0.70
+(0.94%)
As of 8:01:05 AM GMT+2. Market Open.
Loading Chart for 2L9.SG
- Previous Close
74.36 - Open
74.60 - Bid 73.76 x --
- Ask 75.14 x --
- Day's Range
74.16 - 75.24 - 52 Week Range
66.48 - 111.15 - Volume
375 - Avg. Volume
41 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Apr 30, 2025 - May 5, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 2L9.SG
View MorePerformance Overview: 2L9.SG
Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
2L9.SG
11.26%
S&P 500 (^GSPC)
6.62%
1-Year Return
2L9.SG
10.28%
S&P 500 (^GSPC)
8.80%
3-Year Return
2L9.SG
25.35%
S&P 500 (^GSPC)
27.85%
5-Year Return
2L9.SG
16.41%
S&P 500 (^GSPC)
93.62%
Compare To: 2L9.SG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2L9.SG
View MoreValuation Measures
As of 4/24/2025
Market Cap
4.86B
Enterprise Value
4.73B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
10.40
Price/Book (mrq)
18.02
Enterprise Value/Revenue
10.52
Enterprise Value/EBITDA
278.43
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--